Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
After a meal, glucagon-like peptide-1 (GLP-1) levels in the hepatic portal vein are elevated and are twice those in peripheral blood. The aim of this study was to determine whether any of GLP-1's acute metabolic effects are initiated within the hepatic portal vein. Experiments consisted of a 40-min basal period, followed by a 240-min experimental period, during which conscious 42-h-fasted dogs received glucose intraportally (4 mg·kg−1·min−1) and peripherally (as needed) to maintain arterial plasma glucose levels at ∼160 mg/dl. In addition, saline was given intraportally (CON; n = 8) or GLP-1 (1 pmol·kg−1·min−1) was given into the hepatic portal vein (POR; n = 11) or the hepatic artery (HAT; n = 8). Portal vein plasma GLP-1 levels were basal in CON, 20× basal in POR, and 10× basal in HAT, whereas levels in the periphery and liver were the same in HAT and CON. The glucose infusion rate required to maintain hyperglycemia was significantly greater in POR (8.5 ± 0.7 mg·kg−1·min−1, final 2 h) than in either CON or HAT (6.0 ± 0.5 or 6.7 ± 1.0 mg·kg−1·min−1, respectively). There were no differences among groups in either arterial plasma insulin (24 ± 2, 23 ± 3, and 23 ± 3 μU/ml for CON, POR, and HAT, respectively) or glucagon (23 ± 2, 30 ± 3, and 25 ± 2 pg/ml) levels during the experimental period. The increased need for glucose infusion reflected greater nonhepatic as opposed to liver glucose uptake. GLP-1 infusion increased glucose disposal independently of changes in pancreatic hormone secretion but only when the peptide was delivered intraportally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Vahl, T. P., Tauchi, M., Durler, T. S., Elfers, E. E., Fernandes, T. M., Bitner, R. D., Ellis, K. S., Woods, S. C., Seeley, R. J., Herman, J. P., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0153 · Cited by 318
Prigeon, R. L., Quddusi, S., Paty, B., & D'Alessio, D. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00024.2003 · Cited by 199
Burcelin, R., Dolci, W., & Thorens, B. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1635 · Cited by 137
Sindelar, D. K., Balcom, J. H., Chu, C. A., Neal, D. W., & Cherrington, A. D. (1996) · Diabetes · doi:10.2337/diab.45.11.1594 · Cited by 134 · cited 3×
“ELISA (Linco Research), which recognizes only GLP-1-(7-36) amide”
BackgroundSelf-citation
Cited by
Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
Salehi, M., Vella, A., McLaughlin, T., & Patti, M.-E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00528 · Cited by 239
Chai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., & Liu, Z. (2012) · Diabetes · doi:10.2337/db11-1073 · Cited by 194
“1): In protocol 1, rats received an intravenous infusion of saline (control) or GLP-1 (7-36) amide (30 pmol/kg/min; Bachem Americas, Inc.”
BackgroundMethodInfluentialDirect effect of GLP-1 infusion on endogenous glucose production in humans
Seghieri, M., Rebelos, E., Gastaldelli, A., Astiarraga, B. D., Casolaro, A., Barsotti, E., Pocai, A., Nauck, M., Muscelli, E., & Ferrannini, E. (2013) · Diabetologia · doi:10.1007/s00125-012-2738-3 · Cited by 143
“In catheterised dogs, Johnson et al [29] found that direct infusion of GLP-1 into the portal vein at matched plasma glucose, insulin and glucagon concentrations resulted in a more positive net hepatic glucose balance, which is the net sum of EGP and hepatic glucose uptake.”
BackgroundIncretins in obesity and diabetes
Chia, C. W., & Egan, J. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14211 · Cited by 93
Glucose sensing and the pathogenesis of obesity and type 2 diabetes
Thorens, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.208 · Cited by 78
Metadata
- Authors
- Johnson, K. M. S., Edgerton, D. S., Rodewald, T., Scott, M., Farmer, B., Neal, D., & Cherrington, A. D.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2007-10
- Volume
- 293
- Issue
- 4
- Pages
- E1085-E1091
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2078805099
- Cited by
- 46
- References
- 7
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. https://app.cochat.ai/papers/10.1152/ajpendo.00275.2007
- The paper
- Johnson, K. M. S., Edgerton, D. S., Rodewald, T., Scott, M., Farmer, B., Neal, D., & Cherrington, A. D. (2007). Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00275.2007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.